Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
PKC Pharmaceuticals, Inc. is a biotechnology company based in Woburn, Massachusetts, dedicated to developing small-molecule therapeutics that target intracellular signal transduction pathways, with a particular focus on protein kinase C (PKC) modulators. Originally founded as Alder Research Center Limited Partnership and later known as Procyon Pharmaceuticals, Inc., the company has conducted preclinical research on prostratin, a non-tumor-promoting PKC activator investigated for its potential to eradicate latent HIV reservoirs and inhibit viral replication. In addition to its drug development efforts, PKC Pharmaceuticals operates LC Laboratories (LC Labs) as a division. LC Laboratories is a globally recognized manufacturer and supplier of high-purity signal transduction reagents, including kinase inhibitors and activators, supporting basic biomedical and preclinical research worldwide.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on PKC Pharmaceuticals.